Back to Search Start Over

Data from BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage–Inducible Gene

Authors :
D. Paul Harkin
Peter H. Watson
Patrick G. Johnston
George Reid
Paul B. Mullan
Patrick J. Morrison
Tong F. Lioe
Ethan D. Emberley
Karl Mulligan
Stephen Moore
Colin R. James
Gail E. Stewart
Jennifer E. Quinn
Julia J. Gorski
Richard D. Kennedy
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Evidence is accumulating to suggest that some of the diverse functions associated with BRCA1 may relate to its ability to transcriptionally regulate key downstream target genes. Here, we identify S100A7 (psoriasin), S100A8, and S100A9, members of the S100A family of calcium-binding proteins, as novel BRCA1-repressed targets. We show that functional BRCA1 is required for repression of these family members and that a BRCA1 disease–associated mutation abrogates BRCA1-mediated repression of psoriasin. Furthermore, we show that BRCA1 and c-Myc form a complex on the psoriasin promoter and that BRCA1-mediated repression of psoriasin is dependent on functional c-Myc. Finally, we show that psoriasin expression is induced by the topoisomerase IIα poison, etoposide, in the absence of functional BRCA1 and increased psoriasin expression enhances cellular sensitivity to this chemotherapeutic agent. Therefore, we identified a novel transcriptional mechanism that is likely to contribute to BRCA1-mediated resistance to etoposide.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....5a366737102b08d549f7e9bda9f06511
Full Text :
https://doi.org/10.1158/0008-5472.c.6494102